These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 4844098)

  • 1. Decrease of dopamine and 5-hydroxytryptamine after intracerebral application of 5,6-dihydroxytryptamine.
    Saner A; Pieri L; Moran J; Da Prada M; Pletscher A
    Brain Res; 1974 Aug; 76(1):109-17. PubMed ID: 4844098
    [No Abstract]   [Full Text] [Related]  

  • 2. The association of lesion-induced reductions in brain monoamines with alterations in striatal carbohydrate metabolism.
    Hoffmann PC; Toon R; Kleinman J; Heller A
    J Neurochem; 1973 Jan; 20(1):69-80. PubMed ID: 4687208
    [No Abstract]   [Full Text] [Related]  

  • 3. A quantitative study on the nigro-neostriatal dopamine neuron system in the rat.
    Andén NE; Hfuxe K; Hamberger B; Hökfelt T
    Acta Physiol Scand; 1966; 67(3):306-12. PubMed ID: 5967596
    [No Abstract]   [Full Text] [Related]  

  • 4. Modulation of neostriatal acetylcholine in the rat by dopamine and 5-hydroxytryptamine afferents.
    Butcher SH; Butcher LL; Cho AK
    Life Sci; 1976 Apr; 18(7):733-43. PubMed ID: 1263754
    [No Abstract]   [Full Text] [Related]  

  • 5. Dopamine released from dendrites in the substantia nigra controls the nigral and striatal release of serotonin.
    Hery F; Soubrie P; Bourgoin S; Motastruc JL; Artaud F; Glowinski J
    Brain Res; 1980 Jul; 193(1):143-51. PubMed ID: 6247027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of frontal pole ablation on biogenic amine levels in the brain.
    Nielson HC
    Exp Neurol; 1966 Aug; 15(4):484-9. PubMed ID: 5911101
    [No Abstract]   [Full Text] [Related]  

  • 7. Interactions of tryptamine analogs with 5-hydroxytryptamine and dopamine in rat striatum in vitro.
    Baker GB; Hiob LE; Martin IL; Mitchell PR; Dewhurst WG
    Proc West Pharmacol Soc; 1980; 23():167-70. PubMed ID: 7403121
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of 5-hydroxytryptophan on serotonin in nerve endings.
    McBride WJ; Aprison MH; Hingtgen JN
    J Neurochem; 1974 Aug; 23(2):385-91. PubMed ID: 4547408
    [No Abstract]   [Full Text] [Related]  

  • 9. Kinetic analysis of 3H-serotonin accumulation in four regions of rat brain after lesions in the medial forebrain bundle.
    Yunger LM; Harvey JA
    Life Sci; 1976 Jul; 19(1):105-15. PubMed ID: 940428
    [No Abstract]   [Full Text] [Related]  

  • 10. Effects of tryptophan on serotonin in nerve endings.
    McBride WJ; Hyde TP; Smith JD; Aprison MH; Lane JD
    J Neurochem; 1976 Jan; 26(1):175-8. PubMed ID: 1082926
    [No Abstract]   [Full Text] [Related]  

  • 11. Regional 5-hydroxytryptamine following selective midbrain raphe lesions in the rat.
    Lorens SA; Guldberg HC
    Brain Res; 1974 Sep; 78(1):45-56. PubMed ID: 4458916
    [No Abstract]   [Full Text] [Related]  

  • 12. Effects of chronically administered L-dopa in normal and lesioned cats.
    Langelier P; Roberge AG; Boucher R; Poirier LJ
    J Pharmacol Exp Ther; 1973 Oct; 187(1):15-26. PubMed ID: 4746324
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of the uptake of 5-hydroxytryptamine, noradrenaline and dopamine into rat brain homogenates by various hydroxylated tryptamines.
    Horn AS; Baumgarten HG; Schlosserberger HG
    J Neurochem; 1973 Jul; 21(1):233-6. PubMed ID: 4720899
    [No Abstract]   [Full Text] [Related]  

  • 14. Origins of serotonin innervation of forebrain structures.
    Kellar KJ; Brown PA; Madrid J; Bernstein M; Vernikos-Danellis J; Mehler WR
    Exp Neurol; 1977 Jul; 56(1):52-62. PubMed ID: 862695
    [No Abstract]   [Full Text] [Related]  

  • 15. On the behavioral and neurochemical actions of 6-hydroxydopa and 5,6-dihydroxytryptamine in rats.
    Richardson JS; Cowan N; Hartman R; Jacobowitz DM
    Res Commun Chem Pathol Pharmacol; 1974 May; 8(1):29-44. PubMed ID: 4847904
    [No Abstract]   [Full Text] [Related]  

  • 16. Inhibition of synaptosomal neurotransmitter uptake by hallucinogens.
    Whipple MR; Reinecke MG; Gage FH
    J Neurochem; 1983 Apr; 40(4):1185-8. PubMed ID: 6131933
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased synthesis of striatal dopamine by N,N-dimethyltryptamine.
    Smith TL
    Life Sci; 1977 Dec; 21(11):1597-601. PubMed ID: 271755
    [No Abstract]   [Full Text] [Related]  

  • 18. Retrograde axonal transport of neurotensin in the rat brain.
    Castel MN; Malgouris C; Blanchard JC; Laduron PM
    Eur J Pharmacol; 1989 Jul; 166(2):353-4. PubMed ID: 2792200
    [No Abstract]   [Full Text] [Related]  

  • 19. Neurochemical changes in the substantiae nigrae and caudate nuclei following acute unilateral intranigral infusions of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP).
    Sirinathsinghji DJ; Whittington PE; Audsley AR
    Brain Res; 1986 Dec; 399(2):339-45. PubMed ID: 2435361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Norfenfluramine and serotonin turnover rate in the rat brain.
    Costa E; Revuelta A
    Biochem Pharmacol; 1972 Sep; 21(17):2385-93. PubMed ID: 4647072
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.